Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses
Griffithsin (GRFT) is a red alga-derived lectin with demonstrated broad spectrum antiviral activity against enveloped viruses, including severe acute respiratory syndrome–Coronavirus (SARS-CoV), Japanese encephalitis virus (JEV), hepatitis C virus (HCV), and herpes simplex virus-2 (HSV-2). However,...
Main Authors: | Barton, Christopher, Kouokam, J. Calvin, Hurst, Harrell, Palmer, Kenneth E. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192392/ |
Similar Items
-
Bulk production of the antiviral lectin griffithsin
by: Fuqua, Joshua L., et al.
Published: (2015) -
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
by: Lusvarghi, Sabrina, et al.
Published: (2016) -
Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses
by: Kouokam, Joseph Calvin, et al.
Published: (2016) -
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus
by: Moulaei, Tinoush, et al.
Published: (2015) -
Improving the large scale purification of the HIV microbicide, griffithsin
by: Fuqua, Joshua L, et al.
Published: (2015)